Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Transcutaneous spinal stimulation to improve blood pressure after a recent spinal cord injury

Official title: Neuromodulation of Blood Pressure Using Transcutaneous Spinal Stimulation in Individuals With an Acute Spinal Cord Injury - A Safety, Feasibility and Efficacy Study

Run by Kessler Foundation · NCT05731986 · Data updated 2026-11-12

We will try a noninvasive spinal stimulation to see if it raises and steadies blood pressure in people 7–30 days after a thoracic spinal cord injury who have low blood pressure or dizziness when sitting up.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment12 (estimated)
SponsorKessler Foundation
Academic / other
Locations1 site (West Orange, New Jersey)
StatusRecruiting
StartedDecember 1, 2023
Main results expectedAugust 2026
Study endsAugust 2026
Registry record updatedSeptember 2, 2025
Trial IDNCT05731986 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people 7–30 days after a thoracic (≥T2) spinal cord injury with AIS A–C who have baseline hypotension, a ≥20 mmHg drop in systolic BP on sitting, or symptoms of orthostasis.

Probably not a fit

Patients who are outside the 7–30 day window, have cervical injuries above T2, are ventilator-dependent, have implanted pacemakers/defibrillators or stimulators, significant cardiac disease, recent DVT/PE, or other exclusionary illnesses are unlikely to benefit or are not eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study uses transcutaneous spinal cord stimulation (scTS) in people early after spinal cord injury during their inpatient rehabilitation to determine effects on blood pressure during an orthostatic provocation (sit-up) test. Participants undergo mapping to identify stimulation sites and parameters, followed by 'optimal' stimulation and a sham (placebo-like) stimulation for comparison. The primary focus is whether scTS can raise systolic blood pressure into the normal target range (around 110–120 mmHg) and relieve orthostatic symptoms such as dizziness and nausea. The trial enrolls individuals 7–30 days post-injury with thoracic-level injuries and documented orthostatic hypotension or related symptoms.

Why it matters

Potential benefit: If successful, this approach could reduce orthostatic hypotension, improve tolerance for rehabilitation activities, and lower short- and long-term cardiovascular complications.

How similar studies have gone: Small prior studies using epidural or transcutaneous spinal stimulation in people with chronic (>1 year) spinal cord injury have shown promising blood pressure stabilization, but this approach has not been tested in the acute 7–30 day population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 7-30 days after injury
* Injury level ≥T2 (thoracic level)
* American Spinal Injury Association Impairment Scale (AIS) A-C
* Exhibits at least one of the following hypotensive symptoms:

  1. Baseline hypotension - resting supine or seated SBP \< 90mmHg;
  2. SBP drop ≥ 20 mmHg within 5 minutes of assuming seated position;
  3. Symptoms of orthostasis with a drop of SBP (\<90mmHg) from supine to sitting.

Exclusion Criteria:

* Current illness (e.g., a recent diagnosis of a deep vein thrombosis (DVT) or pulmonary embolism (PE), a pressure injury that might interfere with the intervention, etc.) or infection
* Ventilator-dependent
* History of implanted brain/spine/nerve stimulators
* Cardiac pacemaker/defibrillator or intra-cardiac lines
* Significant coronary artery or cardiac conduction disease, a recent history of myocardial infarction
* Initiated on new cardiac medications within the past 5 days
* Insufficient mental capacity to understand and independently provide consent
* Pregnancy
* Cancer
* Deemed unsuitable by study physician

Where it's running

  • Kessler Foundation
    West Orange, New Jersey, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.